Document is current
Any future updates will be listed below
-
Authors
van Amsterdam, Jan http://orcid.org/0000-0002-8847-4387
Brunt, Tibor M.
Pierce, Mimi
van den Brink, Wim
- License Information
-
More Information
Article History
Received: 22 June 2021
Revised: 7 September 2021
Accepted: 11 September 2021
First Online: 23 September 2021
Declarations
:
: The paper is exempt from ethical committee approval.
: WvB reports personal fees from Lundbeck, Novartis, D&A Pharma, Takeda, Mundipharma, Angelini, Opiant, Idivior, Kinnov Therapeutics, and Camurus for services outside the submitted work. JvA, TMB, and MP report no conflict of interest. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
